Press Release / Oct 02, 2013
Another successful FDA inspection at a Hovione site
The 12th successful inspection in 18 months
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
The 12th successful inspection in 18 months
European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA)
Hovione’s TwinCaps® inhaler in Phase III clinical trials for influenza
Pharmaceutical Technology Sourcing and Management, July 2006
Pharmaceutical Technology Europe, February 2014
Drug Delivery Technology, April 2007